Medical device complications: Difference between revisions
No edit summary |
|||
| Line 1: | Line 1: | ||
== Insulin | == [[Insulin infusion device complication]] == | ||
*External pump visible on the abdomen with subcutaneous catheter placed under a dressing nearby | *External pump visible on the abdomen with subcutaneous catheter placed under a dressing nearby | ||
*Insulin pumps are easily removed by pulling the catheter out from under the dressing removing it from the subcutaneous insertion site | *Insulin pumps are easily removed by pulling the catheter out from under the dressing removing it from the subcutaneous insertion site | ||
| Line 7: | Line 7: | ||
#Local Infection<ref>Richardson T, Kerr D. Skin-Related Complications of Insulin Therapy: Epidemiology and Emerging Management Strategies. Am J Clin Dermatol, 2003; 4 (10): 661-667</ref> | #Local Infection<ref>Richardson T, Kerr D. Skin-Related Complications of Insulin Therapy: Epidemiology and Emerging Management Strategies. Am J Clin Dermatol, 2003; 4 (10): 661-667</ref> | ||
== Intrathecal | == [[Intrathecal drug delivery systems complication]]== | ||
*used for delivery of short or long acting pain medications into the theca space | *used for delivery of short or long acting pain medications into the theca space | ||
Most common Intrathecal medications | Most common Intrathecal medications | ||
| Line 26: | Line 26: | ||
*Consider naloxone to reverse effects taking into account patients chronicity of treatment if they withdrawal | *Consider naloxone to reverse effects taking into account patients chronicity of treatment if they withdrawal | ||
==Vagal | ==[[Vagal nerve stimulator complication]]== | ||
*Used to treat refractory epilepsy | *Used to treat refractory epilepsy | ||
*Implanted in the chest with a single lead stimulating the left vagus nerve. It does not stimulate the right vagus nerve which innervates the heart | *Implanted in the chest with a single lead stimulating the left vagus nerve. It does not stimulate the right vagus nerve which innervates the heart | ||
| Line 39: | Line 39: | ||
#Excessive Pain | #Excessive Pain | ||
==Bladder/Sacral | ==[[Bladder/Sacral nerve stimulators complication]]== | ||
*Single wire system inserted into the S3 sacral foramen to stimulate sacral nerve and treat urinary incontinence | *Single wire system inserted into the S3 sacral foramen to stimulate sacral nerve and treat urinary incontinence | ||
Complications | Complications | ||
| Line 46: | Line 46: | ||
#Stimulator misfiring | #Stimulator misfiring | ||
==Deep | ==[[Deep brain stimulator complication]]== | ||
*Implanted to treat Parkinson's disease and dystonia. | *Implanted to treat Parkinson's disease and dystonia. | ||
*Single lead systems implanted into the thalamus | *Single lead systems implanted into the thalamus | ||
| Line 54: | Line 54: | ||
#Lead Migration | #Lead Migration | ||
==Gastric | ==[[Gastric pacemaker complication]]== | ||
* Inserted into the gastric musculature for gastroparesis management | * Inserted into the gastric musculature for gastroparesis management | ||
Complications | Complications | ||
| Line 61: | Line 61: | ||
#Lead Migration | #Lead Migration | ||
==Phrenic | ==[[Phrenic nerve/diaphragmatic stimulators complication]]== | ||
*Implanted into bilateral phrenic nerves to treat rerspiratory insufficiency from poor diaphragmatic motion | *Implanted into bilateral phrenic nerves to treat rerspiratory insufficiency from poor diaphragmatic motion | ||
Complications | Complications | ||
Revision as of 12:25, 20 July 2015
Insulin infusion device complication
- External pump visible on the abdomen with subcutaneous catheter placed under a dressing nearby
- Insulin pumps are easily removed by pulling the catheter out from under the dressing removing it from the subcutaneous insertion site
Complications:
Intrathecal drug delivery systems complication
- used for delivery of short or long acting pain medications into the theca space
Most common Intrathecal medications
- Clonidine
- Bupivacaine
- Morphine
- Hydromorphone
- Fentanyl
- Baclofen
- Ziconotide
Complications:
- Respiratory depression from medication overdose
- Infection
- The device is not removed in an overdose but should be turned off.
- Insertion of a 22-guage needle into the pump reservoir can remove all medication in case device cannot be turned off
- Consider naloxone to reverse effects taking into account patients chronicity of treatment if they withdrawal
Vagal nerve stimulator complication
- Used to treat refractory epilepsy
- Implanted in the chest with a single lead stimulating the left vagus nerve. It does not stimulate the right vagus nerve which innervates the heart
Complications:
- Hoarseness
- Shortness of Breath
- Pharyngitis
- Infection
- Parasthesias
- Insomnia
- Excessive Pain
Bladder/Sacral nerve stimulators complication
- Single wire system inserted into the S3 sacral foramen to stimulate sacral nerve and treat urinary incontinence
Complications
- Infection (early or late complication)
- Lead Migration
- Stimulator misfiring
Deep brain stimulator complication
- Implanted to treat Parkinson's disease and dystonia.
- Single lead systems implanted into the thalamus
Complications
- Infection (usually early after placement)
- Over or Under stimulation
- Lead Migration
Gastric pacemaker complication
- Inserted into the gastric musculature for gastroparesis management
Complications
- Perforation
- Infection
- Lead Migration
Phrenic nerve/diaphragmatic stimulators complication
- Implanted into bilateral phrenic nerves to treat rerspiratory insufficiency from poor diaphragmatic motion
Complications
- Pneumothorax (early after implantation)
- Infection
- Wire Migration
- Drive malfunction (causing diaphragmatic paralysis)
See Also
References
- ↑ Richardson T, Kerr D. Skin-Related Complications of Insulin Therapy: Epidemiology and Emerging Management Strategies. Am J Clin Dermatol, 2003; 4 (10): 661-667